Nalaganje...

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Human respiratory syncytial virus (hRSV) is the most important viral agent of pediatric respiratory infections worldwide. The only specific treatment available today is a humanized monoclonal antibody (Palivizumab) directed against the F glycoprotein, administered prophylactically to children at ver...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Magro, Margarita, Mas, Vicente, Chappell, Keith, Vázquez, Mónica, Cano, Olga, Luque, Daniel, Terrón, María C., Melero, José A., Palomo, Concepción
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286924/
https://ncbi.nlm.nih.gov/pubmed/22323598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1115941109
Oznake: Označite
Brez oznak, prvi označite!